Skip to content

What should you know before trying HBOT for MS?

Read the controlled evidence on HBOT for multiple sclerosis, the Cochrane conclusion and the established South Wales MS Therapy Centre option.

Hyperbaric oxygen has been used by people with multiple sclerosis in the UK for decades, but controlled research has not shown a consistent clinical benefit. That makes it important to separate long-standing community use from evidence that HBOT changes MS itself.

You may still decide the chamber experience or community model is worth trying. The useful decision is one made without a promise that the treatment will alter disease progression.

Two women talk together on a park bench during an accessible walk.
People living with MS may value different kinds of support. The evidence does not show that HBOT changes the disease, but it can still be discussed as an informed personal choice.

Why it was studied

A plausible mechanism led to clinical trials.

Hyperbaric oxygen therapy means breathing concentrated oxygen inside a pressurised chamber. Pressure helps more oxygen dissolve into the bloodstream and reach tissue. That mechanism prompted researchers to test whether HBOT could affect MS symptoms or progression.

Plausibility is not the same as a reliable outcome. Multiple controlled trials were completed, allowing later reviewers to assess the evidence as a whole rather than relying on individual experiences.

What the review found

Nine trials did not produce a consistent benefit.

Controlled trials
9

Included in the Cochrane review.

Participants
504

Across the included trials.

Overall conclusion
No consistent benefit

Routine use was not justified.

Some individual outcomes appeared positive, but the pattern was not consistent enough to support routine HBOT for MS. The Undersea and Hyperbaric Medical Society likewise states that controlled evidence of benefit is limited. This is why we do not describe HBOT as a treatment that improves or slows multiple sclerosis.

Evidence at a glance

Longstanding use, but no consistent controlled benefit.

Cochrane review

9 trials

504 participants across the included studies.

Evidence conclusion

Not consistent

Routine use was not justified.

Local alternative

Since 1983

South Wales MS Therapy Centre in Swansea.

A local option worth knowing about

South Wales has an established MS therapy charity.

The South Wales MS Therapy Centre in Swansea has offered oxygen therapy since 1983. It operates as a charity, has two multiplace chambers and provides treatment at low cost to members. For someone seeking regular, long-term access, that model may be more suitable than paying commercial session prices in Cardiff.

Visit the South Wales MS Therapy Centre ↗

If you still want to try HBOT

Define what would make it worthwhile.

Choose a symptom or practical outcome you can track, set a review point and avoid interpreting every good day as proof. A single session can establish whether you tolerate the chamber before making a larger commitment.

Keep established care in place

HBOT does not replace your MS team.

Continue disease-modifying treatment, rehabilitation and symptom management as advised. New neurological symptoms or deterioration need appropriate medical assessment, not a chamber booking.

A choice with the evidence visible

Trying it remains your decision. Our job is not to oversell it.

You can book a single Cardiff session with no referral needed, or explore the Swansea charity for lower-cost ongoing access. Either route should begin with realistic expectations.